Compare YCBD & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YCBD | TRIB |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0M | 5.5M |
| IPO Year | 2018 | 1996 |
| Metric | YCBD | TRIB |
|---|---|---|
| Price | $0.38 | $5.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 98.1K | 9.1K |
| Earning Date | 12-18-2026 | 12-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,190,468.00 | N/A |
| Revenue This Year | $14.24 | $35.89 |
| Revenue Next Year | $30.43 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.33 | $0.28 |
| 52 Week High | $2.56 | $14.17 |
| Indicator | YCBD | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 44.22 | 40.72 |
| Support Level | $0.33 | $5.01 |
| Resistance Level | $0.39 | $7.45 |
| Average True Range (ATR) | 0.03 | 0.58 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 26.11 | 26.22 |
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.